Holzkirchen, Germany

Katharina Obermüller

This inventor holds 1 USPTO granted patent. Top assignee: Hexal Ag. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katharina Obermüller. Retrieved from https://idiyas.com/inventor/katharina-obermüller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katharina Obermüller: Innovator in Pharmaceutical Dosage Forms

Introduction

Katharina Obermüller is a notable inventor based in Holzkirchen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for assessing drug formulations. Her work is characterized by a commitment to improving the efficacy and reliability of pharmaceutical products.

Latest Patents

Katharina holds a patent for a "Method and device for determining the disintegration time of film-shaped pharmaceutical dosage forms." This invention relates to a method for determining the disintegration time of a film-shaped pharmaceutical dosage form and a disintegration testing device for use in such a method. This innovation is crucial for ensuring that medications dissolve properly in the body, which is essential for their effectiveness.

Career Highlights

Katharina is currently associated with Hexal AG, a prominent company in the pharmaceutical industry. Her role at Hexal AG allows her to apply her expertise in pharmaceutical sciences and contribute to the development of innovative drug delivery systems.

Collaborations

Throughout her career, Katharina has collaborated with esteemed colleagues such as Jörg Nink and Josef Pichler. These partnerships have fostered a collaborative environment that enhances the research and development of pharmaceutical technologies.

Conclusion

Katharina Obermüller exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly her patented method for determining disintegration times, highlight her dedication to improving drug formulations. Her work continues to impact the field positively, ensuring that patients receive effective and reliable medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…